Prognosis in Carcinoma of the Urinary Bladder Based upon Tissue Blood Group ABH and Thomsen-Friedenreich Antigen Status and Karyotype of the Initial Tumor

Cancer Research

Volumn 43, Issue 2, 1983, Pages 934-

  Summers, Jack L ^a   Coon, John S ^b   Ward, Rose M ^a   Falor, William H ^a   Miller, Alexander W ^b   Weinstein, Ronald S ^b  

^a AKRON CITY HOSPITAL   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THOMSEN FRIEDENREICH ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; BLADDER; BLADDER CARCINOMA; BLOOD GROUP ABO SYSTEM; DIAGNOSIS; GENETIC ENGINEERING; HUMAN; HUMAN EXPERIMENT; KARYOTYPE; METHODOLOGY; PRELIMINARY COMMUNICATION; PROGNOSIS;

ABO BLOOD-GROUP SYSTEM; ADULT; AGED; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CARCINOMA, TRANSITIONAL CELL; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; DISACCHARIDES; FEMALE; HUMANS; KARYOTYPING; MALE; MIDDLE AGED; PROGNOSIS; URINARY BLADDER NEOPLASMS;

EID: 0020678336     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bergman, S., and Javadpour, N. The cell surface antigen A, B, or O (H) as an indicator of malignant potential in Stage A bladder carcinoma. J. Urol., 119: 49–51, 1978.
2. Coon, J., and Weinstein, R. S. Detection of ABH tissue isoantigens by immunoperoxidase methods in normal and neoplastic urothelium. Comparison with the red cell adherence method. Am. J. Clin. Pathol., 76: 163–171, 1981.
3. Coon, J., Weinstein, R. S., and Summers, J. Combination of ABH and T antigen detection in prognosis of urinary bladder carcinoma. Lab. Invest., 46: 15, 1982.
4. Coon, J., Weinstein, R. S., and Summers, J. Blood group precursor T antigen expression in human urinary bladder carcinoma. Am. J. Clin. Pathol., 77: 692–699, 1982.
5. Cummings, K. Carcinoma of the bladder: predictors. Cancer (Phila.), 45: 1849–1855, 1980.
6. Decenzo, J. M., Howard, P., and Irish, C. E. Antigenic deletion and prognosis of patients with Stage A transitional cell bladder carcinoma. J. Urol., 114: 874–878, 1975.
7. Falor, W. Chromosomes in noninvasive papillary carcinoma of the bladder. J. Am. Med. Assoc., 216: 791–794, 1971.
8. Falor, W., and Ward, R. DNA banding patterns in carcinoma of the bladder. J. Am. Med. Assoc., 266: 1322–1327, 1973.
9. Falor, W., and Ward, R. Cytogenetic analysis: a potential index for recurrence of early carcinoma of the bladder. J. Urol., 115: 49–52, 1973.
10. Falor, W., and Ward, R. Prognosis in well differentiated noninvasive carcinoma of the bladder based on chromosomal analysis. Surg. Gynecol. Obstet., 144: 515–518, 1977.
11. Falor, W., and Ward, R. Prognosis in early carcinoma of the bladder based on chromosomal analysis. J. Urol., 119: 44–48, 1978.
12. Farrow, G. M. Pathologist's role in bladder cancer. Semin. Oncol., 6: 198–206, 1979.
13. Friedell, G. H., Bell, J. R., Burney, S. W., Soto, E. A., and Tiltman, A. J. Histopathology and classification of urinary bladder carcinoma. Urol. Clin. North Am., 3: 53–70, 1976.
14. Johnson, J. D., and Lamm, D. L. Prediction of bladder tumor invasion with the mixed cell agglutination test. J. Urol., 123: 25–28, 1980.
15. Lange, P. H., Limas, C., and Fraley, E. E. Tissue blood group antigen and prognosis in low stage transitional cell carcinoma of the bladder. J. Urol., 119: 52–55, 1978.
16. Limas, C., Coon, J., Lange, P., and Weinstein, R. S. ABH antigens in urinary bladder carcinomas: detection and clinical applications. In: W. Bonney and G. Prout (eds.), Bladder Cancer, AUA Monograph, Vol. 1, pp. 69–79. Baltimore: Williams & Wilkins, 1982.
17. Limas, C., Lange, P., Fraley, E. E., and Vessella, R. A, B, H antigens in transitional cell tumors of the urinary bladder. Correlation with the clinical course. Cancer (Phila.), 44: 2099–2107, 1979.
18. Sandberg, A. Chromosome markers and progression in bladder cancer. Cancer Res., 37: 2950–2956, 1977.
19. Sandberg, A. The Chromosomes in Human Cancer and Leukemia, pp. 503–511. Amsterdam: Elsevier/North-Holland Biomedical Press, 1980.
20. Sandberg, A. L. Chromosome studies in bladder cancer. In: J. Connolly (ed.), Carcinoma of the Bladder, pp. 127–141. New York: Raven Press, 1981.
21. Sandberg, A. Chromosomes in bladder cancer. In: W. Bonney and G. Prout (eds.), Bladder Cancer, AUA Monograph, Vol. 1, pp. 81–94. Baltimore: Williams & Wilkins, 1982.
22. Sandberg, A., and Abe, S. Cytogenetic techniques in hematology. Clin. Hematol., 9: 19–38, 1980.
23. Springer, G., Desai, P., Yang, H., and Murthy, M. Carcinoma-associated blood group MN precursor antigens against which all humans possess antibodies. Clin. Immunol. Immunopathol., 7: 426–441, 1977.
24. Summers, J., Falor, W., and Ward, R. A 10-year analysis of chromosomes in non-invasive papillary carcinoma of the bladder. J. Urol., 125: 177–178, 1981.
25. Weinstein, R. S. Origin and dissemination of human urinary bladder cancer. Semin. Oncol., 6: 149–156, 1979.
26. Weinstein, R. S., Coon, J., Alroy, J., and Davidsohn, I. Tissue-associated blood group antigens in human tumors. In: R. D. DeLellis (ed.), Diagnostic Immunohistochemistry, pp. 239–261. New York: Masson, Inc., 1981.
27. Weinstein, R. S., Coon, J., Summers, J., Ward, R., and Falor, W. H. Prognostic value of ABH (O) antigen deletion and marker chromosomes in human urinary bladder carcinoma (abstract). Lab. Invest., 44: 74, 1981.
28. Whitmore, W. Special article: summary of all phases of bladder carcinoma. J. Urol., 119: 77–79, 1978.